financetom
Business
financetom
/
Business
/
X's tumultuous journey under Elon Musk
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
X's tumultuous journey under Elon Musk
Jul 9, 2025 10:43 AM

(Reuters) -The CEO of X, Linda Yaccarino, said on Wednesday she would step down from the role in a surprise move, ending her tenure at the Elon Musk-owned social media platform that has faced several controversies and challenges including a mass exodus of advertisers from the site.

Yaccarino was tasked with boosting advertising revenue and alleviating the company's heavy debt load. She helped implement new features such as rolling out a new video tab and expanding fact-checking via X's community notes. 

X was on track to report its first year of advertising revenue growth this year since its acquisition in 2022, data from research firm Emarketer showed in March, as advertisers returned to the platform amid Musk's growing political influence.

Here is a timeline of events that shaped the platform after Musk announced his bid for X: 

April 2022- Musk made an offer for X, then known as Twitter, for $43 billion in cash.

May 2022- Musk pauses the deal, citing pending details on spam and fake accounts.

July 2022- Musk terminates the deal, citing material breach of multiple provisions of the agreement.

July 2022- Twitter sues Musk for violating his deal, asking a Delaware court to order him to complete the merger. 

October 2022- Musk completes the deal to acquire Twitter for $44 billion.

November 2022- The company announces mass layoffs, targeting teams responsible for communications, content curation, human rights and machine learning ethics among others.

May 2023- Musk names former NBCUniversal advertising chief Linda Yaccarino as Twitter's new CEO, as the company tries to reverse a plunge in ad revenue.

July 2023- Musk renames Twitter as X and unveils a new logo, underscoring a focus on building an "everything app" and marking an end to the iconic blue bird that became synonymous with the platform after 17 years. 

November 2023- Musk endorses an antisemitic post on X that falsely claimed members of the Jewish community were stoking hatred against white people, kicking off a mass exodus of advertisers from the platform. 

August 2024- X files an antitrust lawsuit against the World Federation of Advertisers (WFA) and several major companies, accusing them of unlawfully conspiring to boycott the site and causing it to lose revenue.

March 2025- Musk's xAI acquires X in an all-stock deal that values X at $33 billion.

July 2025- Yaccarino stepped down as X CEO without giving a specific reason for her decision.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
ING Comments on Euro, Poland's Zloty
ING Comments on Euro, Poland's Zloty
Sep 5, 2025
05:58 AM EDT, 09/05/2025 (MT Newswires) -- Bloomberg's latest poll of European Central Bank forecasters shows expectations have turned markedly more hawkish, said ING. Consensus has cemented around the cutting cycle ending at over 2%, and the share of respondents agreeing with the banks 1.75% terminal rate call has shrunk. Interestingly, expectations for rate hikes in the second half of...
Vizsla Silver Enters $220 Million Finance Mandate to Fund Mexican Project Development
Vizsla Silver Enters $220 Million Finance Mandate to Fund Mexican Project Development
Sep 5, 2025
05:59 AM EDT, 09/05/2025 (MT Newswires) -- Vizsla Silver ( VZLA ) said Friday it secured a commitment of up to $220 million to fund the construction and development of the underground Panuco silver-gold project in Sinaloa, Mexico. A syndicate of banks will arrange the facility, with Macquarie Bank retaining a 70% interest and managing syndication of the remaining 30%,...
BioNTech's Breast Cancer Drug Meets Primary Endpoint in Phase 3 Interim Analysis
BioNTech's Breast Cancer Drug Meets Primary Endpoint in Phase 3 Interim Analysis
Sep 5, 2025
06:01 AM EDT, 09/05/2025 (MT Newswires) -- BioNTech (BNTX) and China's Duality Biologics said Friday that their phase 3 trial evaluating trastuzumab pamirtecan in patients with a certain type of breast cancer met its primary endpoint in an interim analysis. A joint statement said the study, which compared BioNTech's trastuzumab pamirtecan drug candidate with Roche's approved antibody drug-conjugate trastuzumab emtansine,...
US clothing retailers test full-price strategy as rich shoppers keep spending
US clothing retailers test full-price strategy as rich shoppers keep spending
Sep 5, 2025
NEW YORK (Reuters) -A handful of apparel retailers including Levi's and Aritzia are teasing more full-priced products, testing how much wealthier shoppers are willing to pay despite the sobering effect of tariffs. They have not been disappointed so far. Levi Strauss, for instance, raised prices on some products in July but saw no slowdown in demand, the denim maker's chief financial...
Copyright 2023-2026 - www.financetom.com All Rights Reserved